Latest News about ALPMY
Recent news which mentions ALPMY
From Benzinga
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
March 26, 2021
From Benzinga
Aveo Pharma's Stock Trading Higher On Much Awaited FDA Approval For Tivozanib In Relapsed Kidney Cancer
March 11, 2021
From Benzinga
Astellas Pharma's Fezolinetant Topped Placebo For Reducing Severity Of Menopausal Hot Flash In Phase 3 Studies
February 19, 2021
From Benzinga
Seagen/Astellas Pharma Seek Approval For PADCEV's Expanded Use In Urothelial Cancer Settings
February 18, 2021
From Benzinga
Where Will Pfizer Be in 5 Years?
January 19, 2021
From Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
August 21, 2020
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
May 27, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
March 24, 2020
From Benzinga
From Benzinga
FibroGen's Anemia Drug Goes to FDA for Review
February 12, 2020
From Motley Fool
Seattle Genetics, Astellas, and Merck Hit a Bladder Cancer Bullseye
February 11, 2020
From Motley Fool
Stocks That Hit 52-Week Highs On Tuesday
February 11, 2020
From Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
February 11, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
February 10, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
February 06, 2020
From Benzinga
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
February 02, 2020
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
January 31, 2020
From Benzinga
The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance
January 30, 2020
From Benzinga
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
January 15, 2020
From Benzinga
Why Adaptimmune Therapeutics Is Jumping 11.5% Today
January 14, 2020
From Motley Fool
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
January 14, 2020
From Benzinga
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
December 27, 2019
From Benzinga
A Perspective On Biopharma's Record M&A Run In 2019
December 23, 2019
From Benzinga
From Benzinga
The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic
December 19, 2019
From Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
December 17, 2019
From Benzinga
There’s more upside for biotech even after 24% gains in two months
December 12, 2019
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.